Professional Research Network of Kansas, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Wichita KS United States (2000)

Organization Overview

First Clinical Trial
2011
NCT01461369
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Professional Research Network of Kansas, LLC, Wichita, KS 67203

Active Ingredients

Drugs in Phase 3 Trials (2)

diclofenac (voltaren) (2 trials)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (1)

favipiravir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3